(Q79863817)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Michiya Kobayashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Junichi Sakamoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ken Kondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Naoki Nagata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Takehiro Okabayashi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tsutomu Namikawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kazuhiro Hanazaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

23 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

52-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17334719%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10120-006-0411-6

26 December 2019

exact match

0 references

cites work

Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen

1 reference

12 December 2020

A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer

1 reference

12 December 2020

Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.

1 reference

12 December 2020

Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer

1 reference

12 December 2020

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG).

1 reference

12 December 2020

Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas

1 reference

12 December 2020

A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

1 reference

12 December 2020

Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro

1 reference

12 December 2020

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the

1 reference

12 December 2020

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

1 reference

12 December 2020

Selecting drug combinations based on total equivalent dose (dose intensity)

1 reference

12 December 2020

Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Theoretical concepts and the emerging role of taxanes in adjuvant therapy

1 reference

12 December 2020

Cytotoxicity of paclitaxel in comparison with other anticancer agents against neoplastic cells obtained from clinical gastrointestinal carcinoma tissue.

1 reference

12 December 2020

1 reference

12 December 2020

Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach

1 reference

12 December 2020

Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

1 reference

12 December 2020

Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.

1 reference

12 December 2020

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

1 reference

12 December 2020

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

1 reference

12 December 2020